Bohai Securities pointed out that the pharmaceutical and biotechnology sector has recently experienced significant gains, with the momentum of innovative drugs and CXO continuing and catalysts emerging frequently. On the policy front, recent measures such as the "Several Measures to Support the High-Quality Development of Innovative Drugs" and the notice related to the 11th centralized procurement batch are of great significance to the pharmaceutical and medical device sectors. The innovative drug policy supports development across the entire chain, from R&D to market access and payment, with the commercial insurance innovative drug catalog process advancing steadily. The 11th centralized procurement batch adheres to the principles of "stabilizing clinical use, ensuring quality, preventing bid-rigging, and countering involution," optimizing the rules. In terms of performance, the sector shows signs of recovery, and a turning point in performance is expected. The medical device sector is focused on investment opportunities brought by the optimization of centralized procurement rules.

Medical ETF (159828) tracks the CSI Medical Index (399989), which selects listed securities from the Shanghai and Shenzhen markets involved in medical devices, medical services, biopharmaceuticals, and other related fields as index samples to reflect the overall performance of listed companies in the medical industry. The CSI Medical Index emphasizes the healthcare sector, covering representative companies in the industry, and effectively captures the market characteristics and development trends of the medical industry.

Investors without stock accounts can consider Cathay CSI Medical ETF Connect A (012634) and Cathay CSI Medical ETF Connect C (012635).

Note: Any mentioned stocks are for reference only and do not constitute investment advice. Short-term gains/losses and historical performance of indices/funds are for analytical purposes only and do not predict future performance. Market views may change with market conditions and do not constitute any investment advice or commitment. Indices mentioned are for reference only and do not constitute investment advice or guarantees of fund performance. When purchasing related fund products, please choose products that match your risk tolerance. Funds carry risks; invest with caution.